Predicting treatment efficacy via quantitative magnetic resonance imaging: a Bayesian joint model
Abstract:Summary. The prognosis for patients with high grade gliomas is poor, with a median survival of 1 year. Treatment efficacy assessment is typically unavailable until 5–6 months post diagnosis. Investigators hypothesize that quantitative magnetic resonance imaging can assess treatment efficacy 3 weeks after therapy starts, thereby allowing salvage treatments to begin earlier. The purpose of this work is to build a predictive model of treatment efficacy by using quantitative magnetic resonance imaging data and to assess its performance. The outcome is 1‐year survival status. We propose a joint, two‐stage Bayesian model. In stage I, we smooth the image data with a multivariate spatiotemporal pairwise difference prior. We propose four summary statistics that are functionals of posterior parameters from the first‐stage model. In stage II, these statistics enter a generalized non‐linear model as predictors of survival status. We use the probit link and a multivariate adaptive regression spline basis. The hybrid Metropolis‐within‐Gibbs algorithm and reversible jump Markov chain Monte Carlo methods are applied iteratively between the two stages to estimate the posterior distribution. Through both simulation studies and model performance comparisons we find that we can achieve higher overall correct classification rates by accounting for the spatiotemporal correlation in the images and by allowing for a more complex and flexible decision boundary provided by the generalized non‐linear model.
Document Type: Research Article
Affiliations: University of Michigan, Ann Arbor, USA
Publication date: January 1, 2012